JP5745734B2 - 脂質系および使用方法 - Google Patents

脂質系および使用方法 Download PDF

Info

Publication number
JP5745734B2
JP5745734B2 JP2006525335A JP2006525335A JP5745734B2 JP 5745734 B2 JP5745734 B2 JP 5745734B2 JP 2006525335 A JP2006525335 A JP 2006525335A JP 2006525335 A JP2006525335 A JP 2006525335A JP 5745734 B2 JP5745734 B2 JP 5745734B2
Authority
JP
Japan
Prior art keywords
acid
omega
fatty
lipid system
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006525335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504225A5 (enExample
JP2007504225A (ja
Inventor
マスタツド，ビツキー・エイ
デミチエル，ステイーブン
ジンカー，ブラツドリー・エイ
ホワン，ユン−シヨン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2007504225A publication Critical patent/JP2007504225A/ja
Publication of JP2007504225A5 publication Critical patent/JP2007504225A5/ja
Application granted granted Critical
Publication of JP5745734B2 publication Critical patent/JP5745734B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2006525335A 2003-09-05 2004-08-04 脂質系および使用方法 Expired - Fee Related JP5745734B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/656,662 2003-09-05
US10/656,662 US7759507B2 (en) 2003-09-05 2003-09-05 Lipid system and methods of use
PCT/US2004/025161 WO2005025334A1 (en) 2003-09-05 2004-08-04 Lipid system and methods of use

Publications (3)

Publication Number Publication Date
JP2007504225A JP2007504225A (ja) 2007-03-01
JP2007504225A5 JP2007504225A5 (enExample) 2015-05-21
JP5745734B2 true JP5745734B2 (ja) 2015-07-08

Family

ID=34226392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006525335A Expired - Fee Related JP5745734B2 (ja) 2003-09-05 2004-08-04 脂質系および使用方法

Country Status (13)

Country Link
US (2) US7759507B2 (enExample)
EP (1) EP1662905A1 (enExample)
JP (1) JP5745734B2 (enExample)
KR (1) KR20060076766A (enExample)
CN (1) CN1874692B (enExample)
AU (2) AU2004271928B2 (enExample)
BR (1) BRPI0414096A (enExample)
CA (1) CA2536692C (enExample)
IL (1) IL173967A (enExample)
MX (1) MXPA06002481A (enExample)
NZ (1) NZ545470A (enExample)
WO (1) WO2005025334A1 (enExample)
ZA (1) ZA200602768B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344747B2 (en) * 2004-04-29 2008-03-18 Gfa Brands, Inc. Oxidative stabilization of omega-3 fatty acids in low linoleic acid-containing peanut butter
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
JP2009502950A (ja) * 2005-07-28 2009-01-29 レリアント ファーマスーティカルズ インコーポレイテッド ジヒドロピリジンカルシウムチャネルブロッカー及びω３脂肪酸を用いた治療法、並びにそれらの混合生成物
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2007132888A1 (ja) * 2006-05-16 2007-11-22 National Institute Of Advanced Industrial Science And Technology 平滑筋収縮抑制剤
AU2007340638B2 (en) * 2006-12-28 2010-11-25 The Nisshin Oillio Group, Ltd. Oil-and-fat composition, and food or beverage containing the oil-and-fat composition
WO2008085019A1 (en) * 2007-01-11 2008-07-17 Carotino Sdn. Bhd. A method for lowering risk of cardiovascular diseases
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
US20080269328A1 (en) * 2007-04-09 2008-10-30 Mohammed Moghadasian Effects of low n-6:n-3 fatty acid ratio from two dietary sources on plasma and tissue lipid composition
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2009058799A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
US20090155447A1 (en) * 2007-12-12 2009-06-18 Solae, Llc Protein extrudates comprising omega-3 fatty acids
US20110177224A1 (en) * 2008-03-03 2011-07-21 Daniel Perlman Stabilization of omega-3 fatty acids in oil-water emulsions
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US20100130608A1 (en) * 2008-10-01 2010-05-27 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
JP5407362B2 (ja) * 2009-01-26 2014-02-05 株式会社カネカ 水中油型乳化油脂組成物
CN102368913A (zh) * 2009-04-01 2012-03-07 雀巢产品技术援助有限公司 降低肥胖的风险
US20100272875A1 (en) * 2009-04-24 2010-10-28 Monsanto Technology Llc Omega-3 enriched cereal, granola, and snack bars
JP2009219500A (ja) * 2009-06-22 2009-10-01 Suntory Holdings Ltd 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US11986508B1 (en) 2010-04-06 2024-05-21 Juliana Konzny Nutritional and cosmetic product, system and method for use
CN101843336A (zh) * 2010-04-22 2010-09-29 王京南 亚麻油脂肪乳口服溶液、饮料及制造方法
EP2670262B2 (en) * 2011-02-02 2025-10-15 Société des Produits Nestlé S.A. High protein nutritional compositions and using same
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
WO2012145119A2 (en) * 2011-04-17 2012-10-26 Michael Gurin Low inflammatory blended oils
CA3119621C (en) * 2011-04-17 2023-09-12 Omega Foods, LLC Omega-6/omega-3 balanced polyunsaturated fatty acids composition
US10653160B2 (en) 2011-04-17 2020-05-19 Omega Foods, LLC Prepared foods having high efficacy omega 6/omega 3 balanced polyunsaturated fatty acids
US10682327B2 (en) 2011-04-17 2020-06-16 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US8551551B2 (en) 2012-01-06 2013-10-08 Perlman Consulting, Llc Stabilization of omega-3 fatty acids in saturated fat microparticles having low linoleic acid content
HRP20181418T1 (hr) 2012-01-06 2018-11-30 Omthera Pharmaceuticals Inc. Dpa-obogaćeni pripravci omega-3 polinezasićenih masnih kiselina u obliku slobodne kiseline
CN104661654A (zh) 2012-05-07 2015-05-27 翁特拉制药公司 他汀类药物和ω-3脂肪酸的组合物
WO2013186233A1 (en) * 2012-06-12 2013-12-19 Norwegian University Of Science And Technology Composition
CA2877811C (en) 2012-07-31 2019-07-23 Nestec S.A. Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (ibd)
CN104247786A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合健康双合食用油
CN104247787A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合普健康经济型a级双合食用油
CN104413167A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量35克以上人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413170A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量25-30克人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413168A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量30-35克人群24种正营养食用油各种健康指标的脂肪酸科学配比
EP3190099B1 (de) 2015-09-14 2020-10-28 Helmholtz-Zentrum Potsdam - Deutsches GeoForschungsZentrum GFZ Stiftung des Öffentlichen Rechts des Lands Brandenburg Neue fettsäure und ihre verwendung
BR102016016559A2 (pt) * 2016-07-18 2018-02-06 Francisco Pianowski Luiz Apresentação de cloreto de magnésio ingerível
CN120282773A (zh) * 2022-09-01 2025-07-08 苏黎世大学 用于全肠外和肠内营养的具有抗炎作用的脂质乳剂
CN116058417A (zh) * 2022-11-25 2023-05-05 新疆札郎孜生物科技有限公司 一种植物调和油及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4526902A (en) 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5059622A (en) 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB2223943A (en) 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
US5922345A (en) 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
JPH0745616A (ja) * 1993-07-29 1995-02-14 Nec Corp 半導体装置の製造方法
DK0639333T3 (da) 1993-08-20 2000-05-08 Nestle Sa Lipidblanding beregnet til brug i levnedsmidler eller som levnedsmiddel
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
MX9605144A (es) 1994-04-01 1997-12-31 Abbott Lab Producto nutritivo para el tratamiento de la colitis ulcerativa y uso del mismo.
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
DE4417851C1 (de) 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
JP3840670B2 (ja) 1995-01-27 2006-11-01 味の素株式会社 糖尿病患者用脂肪輸液剤
US5895652A (en) 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5922704A (en) 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
CA2333988A1 (en) 1998-06-03 1999-12-09 State Of Israel Ministry Of Agriculture Agriculture Research Organizatn The Volkani Center Matthiola seed oil, mixtures containing it and use thereof
AU5678699A (en) 1998-08-27 2000-03-21 Bowles Fluidics Corporation Water bottle with drinking and spray modes
JP3998355B2 (ja) * 1998-11-26 2007-10-24 日清オイリオグループ株式会社 食用油
AUPQ228199A0 (en) 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
JP4391673B2 (ja) * 2000-08-08 2009-12-24 花王株式会社 油脂組成物
EP1315424B1 (en) 2000-08-08 2010-12-29 Kao Corporation Oil/fat composition
AU2001236616A1 (en) 2000-08-26 2002-03-13 Metagenics, Inc. Improved stability conjugated linoleic acid composition for dietary supplement and food uses
US6809115B2 (en) * 2000-09-21 2004-10-26 Nutrition 21, Inc. Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
DE10130491A1 (de) 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
CN1339262A (zh) 2001-09-21 2002-03-13 阮生 食用香油

Also Published As

Publication number Publication date
US7601757B2 (en) 2009-10-13
AU2011201489A1 (en) 2011-04-21
US20050054724A1 (en) 2005-03-10
CA2536692C (en) 2013-04-16
CA2536692A1 (en) 2005-03-24
WO2005025334A1 (en) 2005-03-24
EP1662905A1 (en) 2006-06-07
CN1874692B (zh) 2011-10-19
KR20060076766A (ko) 2006-07-04
CN1874692A (zh) 2006-12-06
AU2004271928B2 (en) 2011-04-14
US20080039525A1 (en) 2008-02-14
IL173967A0 (en) 2006-07-05
BRPI0414096A (pt) 2006-10-31
US7759507B2 (en) 2010-07-20
IL173967A (en) 2012-04-30
NZ545470A (en) 2009-06-26
AU2004271928A1 (en) 2005-03-24
JP2007504225A (ja) 2007-03-01
MXPA06002481A (es) 2006-06-20
ZA200602768B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
JP5745734B2 (ja) 脂質系および使用方法
JP5572645B2 (ja) ドコサヘキサエン酸およびルテインを含有する乳児用製剤
US11297873B2 (en) Ketogenic nutritional compositions
US8173160B2 (en) Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions
US20130078362A1 (en) Liquid nutritional compositions containing unsaturated fatty acids
JP5816271B2 (ja) 封入された油を含む栄養エマルジョン
CA2758889A1 (en) High fiber nutritional emulsions
AU2010266593B2 (en) Nut butter and related products enriched with omega-3
CA2758854A1 (en) High fiber nutritional emulsions for blood glucose control
JPH04152861A (ja) 栄養補給用栄養組成物
US20070031538A1 (en) Liquid nutritional compositions containing n-3 polyunsaturated fatty acids
JPH07274825A (ja) 易吸収性飲食品およびその製造法
JP2003516946A (ja) 消化管の適応の間における増殖応答を向上させる組成物および短腸症候群における使用
HK1187499B (en) Infant formulas containing docosahexaenoic acid and lutein

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070724

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110412

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110719

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120403

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120802

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120814

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20121019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140213

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141009

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141015

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141114

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141119

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141215

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150114

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150402

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150507

R150 Certificate of patent or registration of utility model

Ref document number: 5745734

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees